Skip to main content
. 2021 Sep 17;13(9):1498. doi: 10.3390/pharmaceutics13091498

Figure 5.

Figure 5

Schematic workflow of the methodology for determining the central nervous system (CNS) drug disposition of actinomycin D (Act D). Despite the use of actinomycin C (Act C) for probe calibration and avoiding nonspecific binding of actinomycin D to the microdialysis equipment, only whole brain tissue measurements were suitable for measurement of the drug´s brain disposition. Created with BioRender (Biorender AG, Münchwilen, Switzerland).